Recent Developments GLP-1 Market (2025-2026) In June 2026 , Novo Nordisk and Eli Lilly introduced GLP-1 pills for obesity, and their competition at the American Diabetes Association (ADA) Scientific Sessions
While most group health plans and health insurance issuers do include additional data such as billing class, plan market type, and payer network, we believe the inclusion of the NPI will allow for a direct crosswalk between the hospital MRFs and the TiC MRFs
We offer two types of GLP-1 medication, semaglutide and tirzepatide
CT2 (Purple): involved in carnitine transport, specifically in the epididymis, contributing to sperm maturation
Patients report less burning with a subcutaneous administration, which gives it a slight advantage over an intramuscular injection, according to the CDC
Helps form a transportation system that carries fatty acids into the mitochondria of cells to be burned, aiding in fat loss